Skip to content

A novel ultrasound-guided nerve block technique for middle clavicle fracture-A comparative study of supraclavicular nerve block combined with subclavian muscle plane block

A novel ultrasound-guided nerve block technique for middle clavicle fracture-A comparative study of supraclavicular nerve block combined with subclavian muscle plane block

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096952
Enrollment
Unknown
Registered
2025-02-10
Start date
2025-02-10
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

clavicular fracture

Interventions

Group ISBSB:interscalene brachial plexus block combined with supraclavicular nerve block
Group SMBSB:subclavius muscle plane block combined with supraclavicular nerve block

Sponsors

The First People's Hospital of Tianshui
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with grade ASA 1-2, aged >18 years, requiring internal fixation due to a unilateral clavicle fracture (no other concomitant injury or dislocation).

Exclusion criteria

Exclusion criteria: 1. Patients who refused to participate in this study; 2. No cooperation or communication in Chinese; 3. Patients participating in other clinical studies; 4. Combined with multiple fractures, including head, chest, pelvis, limb or contralateral clavicle fractures; 5. Patients with serious diseases such as heart, blood vessels, brain, kidney and liver; 6. Patients suffering from severe mental disorders or ingesting any psychotropic drugs; 7. Contraindications of non-steroidal anti-inflammatory drugs; 8. Contraindications to regional anesthesia (severe nerve damage, coagulation dysfunction, local infection at the block site, systemic infection, and/or allergy to local anesthetics); 9. Patients with acute or chronic pain caused by a broken collarbone or ingestion of any pain medication; 10. Patients with subclavian muscle deficiency.

Design outcomes

Primary

MeasureTime frame
The proportion of patients who did not require additional sufentanil during the operation;

Secondary

MeasureTime frame
The onset time of anesthesia (defined as the interval from the completion of the nerve block to the complete loss of pinprick sensation and cold perception over the clavicular skin surface, along with the resolution of clavicular tenderness to palpation);Block-related complications (paresthesia, vascular injury, hematoma, local anesthetic and systemic toxicity, pneumothorax, dyspnea, hoarseness and choking, Horner syndrome, subdural block, and spinal cord injury);General anesthesia rate (defined as the proportion of patients converted to general anesthesia);Duration of surgery;The number of patients experiencing adverse events intraoperatively (defined as the fluctuation of mean arterial pressure or heart rate beyond 30% of the baseline value);The time to the first onset of pain;The time of the first PCA compression after the operation;Sufentanil consumption within 24 hours postoperatively;The NRS scores for resting pain and activity pain (active or passive flexion, abduction and rotation of the upper arm) at 3, 6, 12 and 24 hours postoperatively;Motor block grade (0, impossible to flex the forearm or abduct the arm against gravity; 1, less force compared with the contralateral arm; 2, equal force in both arms) at 3, 6, 12, and 24 h postoperatively;The number of patients with PONV;The dosage of metoclopramide after the operation;The number of patients reporting nerve injury;Satisfaction score of patients and surgeons;Respiratory function before and 30 minutes after block, including diaphragmatic paralysis rate, tidal volume, FEV1 and PEF;

Countries

China

Contacts

Public ContactLi Chenguang

The First People's Hospital of Tianshui

lichguang227@163.com+86 187 9418 9553

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 30, 2026